Literature DB >> 33552789

Suicidal Behavior and Medication Adherence in Schizophrenic Patients.

Zain I Warriach1, Marcos A Sanchez-Gonzalez1, Gerardo F Ferrer1.   

Abstract

Suicide is one of the potential complications in the Schizophrenic patient population. This review article deals with the significance of antipsychotic medication compliance in decreasing suicidal behavior and hospitalizations in Schizophrenic patients. The medication adherence with second-generation antipsychotics (SGA) like clozapine and long-acting injectables (LAIs) like paliperidone is associated with decrease suicidal behavior and all-cause mortality in Schizophrenic patients. Concomitant treatment of depression and substance abuse disorder in this patient population is also associated with decreasing all-cause mortality and hospitalizations. On the other hand, long-term benzodiazepine use is associated with increase mortality in Schizophrenic patients. We also discuss some important physician intervention strategies to improve medication adherence in Schizophrenic patients like motivational interviewing (MI), behavioral tailoring (BT), and psychosocial interventions like cognitive behavior therapy (CBT).
Copyright © 2021, Warriach et al.

Entities:  

Keywords:  medication adherence strategies; schizophrenia; suicide

Year:  2021        PMID: 33552789      PMCID: PMC7854315          DOI: 10.7759/cureus.12473

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  43 in total

1.  Suicidal behavior and insight into illness among patients with schizophrenia spectrum disorders.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  Psychiatr Q       Date:  2011-09

2.  Enhancing medication compliance for people with serious mental illness.

Authors:  J A Cramer; R Rosenheck
Journal:  J Nerv Ment Dis       Date:  1999-01       Impact factor: 2.254

3.  Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report.

Authors:  J A Boczkowski; A Zeichner; N DeSanto
Journal:  J Consult Clin Psychol       Date:  1985-10

4.  A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.

Authors:  Jari Tiihonen; Jari Haukka; Mark Taylor; Peter M Haddad; Maxine X Patel; Pasi Korhonen
Journal:  Am J Psychiatry       Date:  2011-03-01       Impact factor: 18.112

5.  [Factors related to suicide attempts in a Tunisian sample of patients with schizophrenia].

Authors:  S Bouhlel; M M'solly; S Benhawala; Y Jones; Z El-Hechmi
Journal:  Encephale       Date:  2012-09-25       Impact factor: 1.291

6.  Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study.

Authors:  Jari Tiihonen; Ellenor Mittendorfer-Rutz; Minna Torniainen; Kristina Alexanderson; Antti Tanskanen
Journal:  Am J Psychiatry       Date:  2015-12-07       Impact factor: 18.112

7.  Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior.

Authors:  Ira D Glick; Rocco Zaninelli; Chuanchieh Hsu; Frederick K Young; Lilia Weiss; Ibrahim Gunay; Vinod Kumar
Journal:  J Clin Psychiatry       Date:  2004-05       Impact factor: 4.384

8.  Mobile phone text message reminders of antipsychotic medication: is it time and who should receive them? A cross-sectional trust-wide survey of psychiatric inpatients.

Authors:  Katherine Bogart; Sook Kuan Wong; Christine Lewis; Anthony Akenzua; Daniel Hayes; Athanasios Prountzos; Chike Ify Okocha; Eugenia Kravariti
Journal:  BMC Psychiatry       Date:  2014-01-22       Impact factor: 3.630

Review 9.  Suicide in the Early Stage of Schizophrenia.

Authors:  Antonio Ventriglio; Alessandro Gentile; Iris Bonfitto; Eleonora Stella; Massimo Mari; Luca Steardo; Antonello Bellomo
Journal:  Front Psychiatry       Date:  2016-06-27       Impact factor: 4.157

10.  Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.

Authors:  Sylvain Druais; Agathe Doutriaux; Magali Cognet; Annabelle Godet; Christophe Lançon; Pierre Levy; Ludovic Samalin; Pascal Guillon
Journal:  Pharmacoeconomics       Date:  2016-04       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.